Inmunova S Ais An Argentine Biotechnology Company Founded In 2009Focusing On The Research And Development Of Innovative Treatments For Rare Infectious Diseasesoperating Under Grupo Insudinmunova Emphasizes High Scientific Standards And Employs A Team Of 28 Professionals Dedicated To Addressing Unmet Medical Needs Through Advanced Protein And Antibody Engineering The Company Utilizes Its Proprietary Immuno Multi Carrierimca Platform To Design Recombinant Vaccines And Immunomodulatorsinmunova Has Developed Covifaban Active Ingredient For Covid 19 Treatmentwhich Received Approval From Argentine Authorities In Late 2020Additionallyit Is Advancing A Biologic Drug Candidate Aimed At Treating Hemolytic Uremic Syndromehus Targeting Severe Cases Primarily Affecting Childreninmunova Covers The Full Drug Development Lifecycle And Collaborates With Various Entities To Contribute To Global Health Initiatives
